Milestone Scientific Inc. (NYSEAMERICAN:MLSS) saw a large growth in short interest in January. As of January 12th, there was short interest totalling 134,557 shares, a growth of 82.6% from the December 29th total of 73,683 shares. Based on an average daily volume of 46,743 shares, the short-interest ratio is currently 2.9 days. Approximately 0.7% of the shares of the stock are sold short.

Separately, Maxim Group reiterated a “buy” rating and issued a $4.00 price objective on shares of Milestone Scientific in a research report on Friday, October 6th.

In other Milestone Scientific news, CFO Joseph D’agostino sold 52,980 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $1.05, for a total transaction of $55,629.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 112,980 shares of company stock worth $119,529 over the last 90 days.

Shares of Milestone Scientific (NYSEAMERICAN MLSS) opened at $1.02 on Friday. Milestone Scientific has a 1 year low of $0.91 and a 1 year high of $1.80. The company has a market cap of $34.64, a PE ratio of -6.25 and a beta of 0.87.

Milestone Scientific (NYSEAMERICAN:MLSS) last released its quarterly earnings data on Wednesday, November 15th. The medical instruments supplier reported ($0.04) EPS for the quarter. Milestone Scientific had a negative return on equity of 70.11% and a negative net margin of 49.67%.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at

About Milestone Scientific

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.